Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults

• Main Authors: Ho, S., Wong, J.G., Ng, O.T., Lee, C.C., Leo, Y.S., Lye, D.C.B., Wong, C.S.
• 其他作者: MEDICINE
• 格式: Article
• 出版: BioMed Central Ltd. 2021
• 主題: Abacavir; Antiretroviral; HIV; Rilpivirine; Treatment-naïve
• 在線閱讀: https://scholarbank.nus.edu.sg/handle/10635/196593

10.1186/s12981-020-00272-5